TY - JOUR
T1 - Paediatric renal tumours
T2 - an update on challenges and recent developments
AU - Somers, Gino R.
AU - L’Herminé-Coulomb, Aurore
AU - Matoso, Andres
AU - O’Sullivan, Maureen J.
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024.
PY - 2025/1
Y1 - 2025/1
N2 - Paediatric renal tumours include a broad range of neoplasms which largely differ, but also overlap to a smaller extent, with adult kidney cancer. These include the embryonal tumour nephroblastoma, which accounts for the majority of cases of kidney cancer in the first decade of life and, despite boasting a cure in ~ 90% cases, still presents clinical challenges in a small proportion of cases. A variety of less common mesenchymal tumours, including the mostly indolent congenital mesoblastic nephroma, clear cell sarcoma of kidney which continues to be associated with poor outcomes for higher stage disease, and the typically lethal malignant rhabdoid tumour, form the bulk of the remaining presentations in the first decade. All three of these represent the intrarenal form of a wider ‘family’ of genetically related and histologically overlapping entities occurring in soft tissue and other anatomical locations. The latter two are examples of aggressive ‘epigenetic’ tumours driven by dysregulation of chromatin. In the second decade of life, renal cell carcinoma dominates, and with molecular characterisation many distinct subtypes are now described. Herein we discuss the developments in relation to diagnostic categorisation of paediatric renal cancers and how deeper understanding of the underlying biology is already providing therapeutic opportunity, while also focussing on the challenges that remain for the pathologist.
AB - Paediatric renal tumours include a broad range of neoplasms which largely differ, but also overlap to a smaller extent, with adult kidney cancer. These include the embryonal tumour nephroblastoma, which accounts for the majority of cases of kidney cancer in the first decade of life and, despite boasting a cure in ~ 90% cases, still presents clinical challenges in a small proportion of cases. A variety of less common mesenchymal tumours, including the mostly indolent congenital mesoblastic nephroma, clear cell sarcoma of kidney which continues to be associated with poor outcomes for higher stage disease, and the typically lethal malignant rhabdoid tumour, form the bulk of the remaining presentations in the first decade. All three of these represent the intrarenal form of a wider ‘family’ of genetically related and histologically overlapping entities occurring in soft tissue and other anatomical locations. The latter two are examples of aggressive ‘epigenetic’ tumours driven by dysregulation of chromatin. In the second decade of life, renal cell carcinoma dominates, and with molecular characterisation many distinct subtypes are now described. Herein we discuss the developments in relation to diagnostic categorisation of paediatric renal cancers and how deeper understanding of the underlying biology is already providing therapeutic opportunity, while also focussing on the challenges that remain for the pathologist.
KW - Clear cell sarcoma of kidney
KW - Congenital mesoblastic nephroma
KW - Malignant rhabdoid tumour
KW - Nephroblastoma
KW - Paediatric renal tumour
KW - Renal cell carcinoma
KW - Wilms’ tumour
UR - http://www.scopus.com/inward/record.url?scp=85217519174&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85217519174&partnerID=8YFLogxK
U2 - 10.1007/s00428-024-04017-x
DO - 10.1007/s00428-024-04017-x
M3 - Review article
C2 - 39786574
AN - SCOPUS:85217519174
SN - 0945-6317
VL - 486
SP - 49
EP - 64
JO - Virchows Archiv
JF - Virchows Archiv
IS - 1
ER -